Study to Determine Whether Ramelteon Helps People With REM Sleep Behavior Disorder

Completed · Phase 4 · Has a placebo group

Conditions studied: REM Sleep Behavior Disorder

In brief

The purpose of this study is to determine whether the use of the drug ramelteon decreases the symptoms of REM Sleep Behavior Disorder.

Key facts

Study ID

NCT01401413

Run by

Sleep Medicine Centers of WNY

People needed

20

Starts

2008-01-01

Expected to finish

2010-09-01

Last updated by the study team

2011-07-25

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets criteria for RBD as determined by screening PSG's
• steady bed partner for completion of RBD questionnaire

You may not qualify if…

• Hepatic impairment
• RBD associated with narcolepsy
• use of fluvoxamine, rifampin, fluconazole or ketoconazole
• current alcohol or drug abuse

Where it is running

• Sleep Medicine Centers of WNY — West Seneca, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.